Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02693509

Get With The Guidelines-Heart Failure Registry

Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–125 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Get With The Guidelines-Heart Failure was initiated in 2005 with over 500 U.S. hospitals participating is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Peer-reviewed research(with over 35 manuscripts) has demonstrated that through participating in Get With The Guidelines-Heart Failure, hospitals will provide equitable care (regardless of race, ethnicity, age, or gender), the importance of scheduled physician follow-up after heart failure hospital discharge, the value in device-support as necessary for the acute heart failure patient, and many other significant findings.

Achievement measures tracked through Get With The Guidelines-Heart Failure:

  • Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) at discharge
  • Evidence-based specific beta blockers
  • Measure left ventricular function
  • Post-discharge appointment for heart failure patients

Quality Measures tracked through Get With The Guidelines-Heart Failure:

  • Mineralocorticoid receptor antagonist at discharge
  • Aldosterone antagonist at discharge
  • Anticoagulation for atrial fibrillation
  • Hydralazine nitrate at discharge
  • DVT prophylaxis
  • CRT-D or CRT-P placed or prescribed at discharge
  • ICD counseling, or ICD placed or prescribed at discharge
  • Influenza vaccination during flu season
  • Pneumococcal vaccination
  • Follow-up visit within 7 days or less
  • Lab monitoring follow-up
  • SGLT-2 inhibitor at discharge
  • Defect-free care for quadruple therapy medication for patients with heart failure with reduced ejection fraction
  • Direct-acting oral anticoagulant at discharge for non-valvular atrial fibrillation or atrial flutter patients

Additional measures collected by Get With The Guidelines-Heart Failure can be viewed at: http://www.heart.org/idc/groups/heart-public/@wcm/@private/@hcm/@gwtg/documents/downloadable/ucm_310967.pdf

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients hospitalized with congestive heart failure.

Exclusion criteria

  • Patients who do not have congestive heart failure,
  • Patients under age of 18,
  • Patients not admitted as inpatients.

Treatment and study plan

GWTG Heart Failure program

Other

Evidence based guideline recommended therapies and counseling prior to hospital discharge

Primary outcomes

  1. 30 day readmission rate

    Time frame: 30 days post discharge from hospital

    Percent of index encounters where there is a readmission within 30 days

  2. 60 day readmission rate

    Time frame: 60 days post discharge from hospital

    Percent of index encounters where there is a readmission within 60 days

  3. 90 day readmission rate

    Time frame: 90 days post discharge from hospital

    Percent of index encounters where there is a readmission within 90 days

Study contacts

Contact information is provided by the study sponsor or research team.

Amy Bennett, JD

CONTACT

[email protected]

214-706-4881

Christine Rutan

CONTACT

[email protected]

214-706-4881

Sponsors and collaborators

Lead sponsor

American Heart Association

Other

Registry information

Important dates

Study start
2005
Primary completion
2040
Study completion
2040
First posted
Feb 26, 2016
Registry last updated
Jan 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.